Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Human Complement System WP2806	12/97	5.312794861176391E-6	0.0025076391744752566	0	0	4.958370348945314	60.22135415725668	FCN1;FCN2;PRNP;CR1;C1R;ITGA2;FPR1;WAS;SERPING1;CD59;VSIG4;PRKACA
Interleukin-11 Signaling Pathway WP2332	5/44	0.004616475433502032	1.0	0	0	4.554563672800145	24.49500709701657	IL11;RPS6KB1;FES;ITGA2;MAPK3
Prion disease pathway WP3995	4/33	0.008834014495511208	1.0	0	0	4.858201250986823	22.975141676962267	PRNP;SPI1;IRF4;MAPK3
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	5/55	0.011837257246385426	1.0	0	0	3.6436509382401168	16.165069513023667	RASSF1;PCNA;BAX;BAK1;TP53BP1
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	3/22	0.016710758224010344	1.0	0	0	5.465476407360175	22.36310381821747	GSK3A;BAX;BAK1
Glycogen Synthesis and Degradation WP500	4/40	0.01721887297349511	1.0	0	0	4.008016032064129	16.27955603534299	HK3;PPP2CB;GSK3A;PYGL
IL-5 Signaling Pathway WP127	4/40	0.01721887297349511	1.0	0	0	4.008016032064129	16.27955603534299	GSK3A;RPS6KB1;BTK;MAPK3
Tgif disruption of Shh signaling WP3674	2/9	0.019912211750142357	1.0	0	0	8.90670229347584	34.882405519263955	TGIF1;TGIF2
MAPK Signaling Pathway WP382	12/246	0.02112992733437905	1.0	0	0	1.9551297717385991	7.541062390808609	DUSP10;RRAS;LRRK2;HSPA6;CACNA2D3;ARRB1;HSPA2;PRKACA;HSPA1B;HSPA1A;MAP2K6;MAPK3
Vitamin A and Carotenoid Metabolism WP716	4/43	0.021940344052406784	1.0	0	0	3.728387006571282	14.240306259941201	SULT1A1;RBP7;ALDH1A1;CD36
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	3/27	0.028968891579981497	1.0	0	0	4.45335114673792	15.77168883942596	RPS6KB1;PRKACA;MAPK3
NRF2 pathway WP2884	8/146	0.030256488359521508	1.0	0	0	2.1961731682543166	7.682311749595384	HGF;MAFG;TXNRD1;SLC39A11;SLC7A11;GCLM;SLC5A3;HSPA1A
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ WP3849	2/12	0.0347505757360525	1.0	0	0	6.68002672010688	22.44194481739897	RRAS;MAP2K6
MAPK Cascade WP422	3/29	0.034896686429043866	1.0	0	0	4.14622348144565	13.912086513749546	RRAS;MAPK3;MAP2K6
Development of pulmonary dendritic cells and macrophage subsets WP3892	2/13	0.040402734490517254	1.0	0	0	6.16617851086789	19.78639007798208	SPI1;IRF4
Dopamine metabolism WP2436	2/13	0.040402734490517254	1.0	0	0	6.16617851086789	19.78639007798208	PPP2CB;PRKACA
Ebola Virus Pathway on Host WP4217	7/129	0.04305042893182533	1.0	0	0	2.1748924204999147	6.8408698302322435	BST2;HLA-DMA;GSN;ITGA2;TYRO3;ASGR1;MAPK3
Genes related to primary cilium development (based on CRISPR) WP4536	6/103	0.04422228412323768	1.0	0	0	2.3347666206198805	7.281031463929472	ARL13B;BBS12;CEP19;WDR19;TULP3;LZTFL1
Signaling of Hepatocyte Growth Factor Receptor WP313	3/34	0.05220691871825585	1.0	0	0	3.536484734174231	10.44161352250808	HGF;MET;MAPK3
Fatty Acid Omega Oxidation WP206	2/15	0.05264396193280757	1.0	0	0	5.344021376085505	15.733887669292315	ALDH2;ALDH1A1
Phytochemical activity on NRF2 transcriptional activation WP3	2/15	0.05264396193280757	1.0	0	0	5.344021376085505	15.733887669292315	SLC7A11;GCLM
Nuclear Receptors Meta-Pathway WP2882	13/319	0.05794375042186246	1.0	0	0	1.6333607654179831	4.652272981231376	IL11;SERPINB2;HGF;TXNRD1;SLC39A11;SLC7A11;SLC5A3;SULT1A1;FGD4;MAFG;BAX;GCLM;HSPA1A
Viral Acute Myocarditis WP4298	5/84	0.058935557970097745	1.0	0	0	2.3857238286096	6.754725331133143	HLA-DMA;CD4;BAX;AIF1;MAPK3
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	2/16	0.059195084025969825	1.0	0	0	5.01002004008016	14.162909722655604	UNC13D;TBC1D10A
Kit receptor signaling pathway WP304	4/59	0.0595451283860539	1.0	0	0	2.7172990047892394	7.665556995065044	RPS6KB1;BTK;SH2B2;MAPK3
Photodynamic therapy-induced HIF-1 survival signaling WP3614	3/37	0.06422834016420031	1.0	0	0	3.2497427287006446	8.921553583201426	SLC16A1;BAX;BAK1
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	2/17	0.06600916139257469	1.0	0	0	4.715312978898974	12.816040257505042	LRP1;FZD7
G13 Signaling Pathway WP524	3/39	0.07288556638628464	1.0	0	0	3.083089255433945	8.074193468562376	RPS6KB1;WAS;PKN1
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	2/18	0.07306905370565892	1.0	0	0	4.45335114673792	11.651526803744126	MAPK3;MAP2K6
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301	2/18	0.07306905370565892	1.0	0	0	4.45335114673792	11.651526803744126	RRAS;MAPK3
Spinal Cord Injury WP2431	6/118	0.07527236057966526	1.0	0	0	2.03797425359193	5.271510347338678	EFNB2;LTB;LILRB2;LILRB3;AIF1;MAPK3
Apoptosis Modulation and Signaling WP1772	5/91	0.077374648832407	1.0	0	0	2.202206611024246	5.635658319942324	TNFRSF10C;BAX;BAK1;MAPK3;HSPA1A
Ferroptosis WP4313	3/40	0.07739908621583053	1.0	0	0	3.006012024048096	7.691724362083672	PRNP;SLC7A11;GCLM
Oxidative Damage WP3941	3/40	0.07739908621583053	1.0	0	0	3.006012024048096	7.691724362083672	PCNA;C1R;BAK1
Non-small cell lung cancer WP4255	4/66	0.08258943168134009	1.0	0	0	2.4291006254934113	6.057869806005826	RASSF1;BAX;BAK1;MAPK3
Integrated Breast Cancer Pathway WP1984	7/151	0.08450516779138412	1.0	0	0	1.858020677115821	4.591062422689585	GSK3A;RRAS;PKIA;BAX;BAK1;SIRT1;RPP38
Vitamin D Receptor Pathway WP2877	8/182	0.08642602523327252	1.0	0	0	1.761765288819397	4.313623168185097	LRRC25;CDKN2D;STEAP4;DUSP10;IRF4;ALOX5;ABCD1;SLC8A1
Nanomaterial induced apoptosis WP2507	2/20	0.08786114136940477	1.0	0	0	4.008016032064129	9.74748557011972	BAX;BAK1
Nicotine Activity on Dopaminergic Neurons WP1602	2/21	0.09556240546555268	1.0	0	0	3.81715812577536	8.962594845063215	CHRNA6;PRKACA
Parkin-Ubiquitin Proteasomal System pathway WP2359	4/70	0.09745158890211275	1.0	0	0	2.290294875465216	5.3327215536630534	HSPA6;HSPA2;HSPA1B;HSPA1A
NAD+ biosynthetic pathways WP3645	2/22	0.10344757711016117	1.0	0	0	3.6436509382401168	8.266315525388785	BST1;SIRT1
NRF2-ARE regulation WP4357	2/23	0.11150273046053624	1.0	0	0	3.485231332229677	7.6455735817600345	SLC7A11;GCLM
Wnt Signaling Pathway and Pluripotency WP399	5/102	0.11184507170902207	1.0	0	0	1.964713741207906	4.303981794227358	PPP2CB;FZD2;FZD7;LRRK2;NKD1
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	3/47	0.11217028588938205	1.0	0	0	2.5583081055728476	5.59690569039288	FES;BTK;MAPK3
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	6/132	0.1130468180089141	1.0	0	0	1.8218254691200584	3.9714943111916874	GSK3A;SESN3;RPS6KB1;FBP1;MAP2K6;MAPK3
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	4/74	0.11346553890858065	1.0	0	0	2.1664951524670966	4.714848313088854	ITGA2;LMNA;CACNA2D3;SLC8A1
Differentiation Pathway WP2848	3/48	0.1175539758693608	1.0	0	0	2.50501002004008	5.362869944325314	CSF1R;IL11;HGF
Secretion of Hydrochloric Acid in Parietal Cells WP2597	1/5	0.11868930417379521	1.0	0	0	8.016032064128257	17.084136989836733	HRH2
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868	1/5	0.11868930417379521	1.0	0	0	8.016032064128257	17.084136989836733	MAPK3
miRNA regulation of p53 pathway in prostate cancer WP3982	2/24	0.11971451765829587	1.0	0	0	3.34001336005344	7.089663961514514	SESN3;BAX
Leptin signaling pathway WP2034	4/76	0.1218806759806774	1.0	0	0	2.1094821221390148	4.439853978693021	GSK3A;RPS6KB1;BAX;MAPK3
Signal Transduction of S1P Receptor WP26	2/25	0.128070148628957	1.0	0	0	3.2064128256513027	6.5897463054613805	S1PR1;MAPK3
Photodynamic therapy-induced AP-1 survival signaling. WP3611	3/50	0.128601317189854	1.0	0	0	2.4048096192384767	4.932356452177673	BAX;BAK1;MAP2K6
Cytokines and Inflammatory Response WP530	2/26	0.13655737173852805	1.0	0	0	3.083089255433945	6.138462916245079	IL11;CD4
Arylamine metabolism WP694	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	SULT1A1
SCFA and skeletal muscle substrate metabolism WP4030	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	FFAR2
Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	SIRT1
Eicosanoid Synthesis WP167	2/27	0.1451644549749239	1.0	0	0	2.9689007644919467	5.72964597939032	ALOX5;TBXAS1
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	3/53	0.1458226766234209	1.0	0	0	2.2686883200362993	4.368050680466394	RPS6KB1;PKN1;HSPD1
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	6/144	0.15171879163017835	1.0	0	0	1.67000668002672	3.149175896235823	NCF1;RPS6KB1;SORT1;CAMK1;SH2B2;MAPK3
IL-4 Signaling Pathway WP395	3/54	0.15172330275644763	1.0	0	0	2.22667557336896	4.19883498917209	RPS6KB1;FES;MAPK3
TGF-beta Receptor Signaling WP560	3/54	0.15172330275644763	1.0	0	0	2.22667557336896	4.19883498917209	TGIF1;SKIL;MAPK3
Hematopoietic Stem Cell Differentiation WP2849	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	SPI1;LMO2;CBFA2T3
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	SPI1;MAPK3;MAP2K6
Disorders of the Krebs cycle WP4236	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	SUCLA2
Cannabinoid receptor signaling WP3869	2/29	0.16269376292415	1.0	0	0	2.764148987630433	5.0193783437657435	PRKACA;MAPK3
miRs in Muscle Cell Differentiation WP2012	2/29	0.16269376292415	1.0	0	0	2.764148987630433	5.0193783437657435	PRKACA;EZH2
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	4/86	0.16760707324407684	1.0	0	0	1.864193503285641	3.3296973271151256	FZD2;FZD7;NKD1;EZH2
Calcium Regulation in the Cardiac Cell WP536	6/149	0.16937081345091762	1.0	0	0	1.6139661874083737	2.865862955903672	GNG4;PKIA;ARRB1;CAMK1;PRKACA;SLC8A1
Extracellular vesicle-mediated signaling in recipient cells WP2870	2/30	0.17159496050911424	1.0	0	0	2.6720106880427523	4.709735364120289	HGF;MET
Complement and Coagulation Cascades WP558	3/58	0.17603867561833744	1.0	0	0	2.073111740722825	3.6011019838025167	CR1;C1R;SERPING1
Ras Signaling WP4223	7/184	0.17750833672175648	1.0	0	0	1.5247887078504836	2.6359597294723383	CSF1R;RASSF1;RRAS;GNG4;PRKACA;MET;MAPK3
Ethanol effects on histone modifications WP3996	2/31	0.18057393039320113	1.0	0	0	2.5858167948800825	4.425922809233922	ALDH2;ALDH1A1
Tumor suppressor activity of SMARCB1 WP4204	2/31	0.18057393039320113	1.0	0	0	2.5858167948800825	4.425922809233922	SMARCD3;EZH2
MET in type 1 papillary renal cell carcinoma WP4205	3/59	0.1822794030321869	1.0	0	0	2.03797425359193	3.469069503609821	HGF;MET;MAPK3
Pancreatic adenocarcinoma pathway WP4263	4/89	0.18236980726912694	1.0	0	0	1.8013555200288216	3.065400455502161	RPS6KB1;BAX;BAK1;MAPK3
ApoE and miR-146 in inflammation and atherosclerosis WP3926	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	SPI1
Caloric restriction and aging WP4191	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	SIRT1
Insulin signalling in human adipocytes (diabetic condition) WP3635	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	RPS6KB1
Insulin signalling in human adipocytes (normal condition) WP3634	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	RPS6KB1
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	4/90	0.1873837580305699	1.0	0	0	1.7813404586951682	2.983026645281452	CD4;IRF4;WAS;MAPK3
Breast cancer pathway WP4262	6/154	0.18783408010595262	1.0	0	0	1.5615646878171927	2.611242628309546	FZD2;RPS6KB1;FZD7;BAX;BAK1;MAPK3
Amino Acid metabolism WP3925	4/91	0.19244164904232453	1.0	0	0	1.761765288819397	2.9033227652017337	ARG2;ALDH1A1;HNMT;GCLM
Myometrial Relaxation and Contraction Pathways WP289	6/156	0.19543060612264207	1.0	0	0	1.5415446277169724	2.5166485562862424	GNG4;PKIA;ARRB1;PRKACA;DGKZ;SLC8A1
TNF alpha Signaling Pathway WP231	4/92	0.19754192618224412	1.0	0	0	1.7426156661148384	2.826181811802842	BAX;PYGL;MAPK3;MAP2K6
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	3/62	0.2013386909469256	1.0	0	0	1.939362596160062	3.108345903560575	CD4;RRAS;MAPK3
DNA Mismatch Repair WP531	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	PCNA
Degradation pathway of sphingolipids, including diseases WP4153	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	GLA
Folate-Alcohol and Cancer Pathway Hypotheses WP1589	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	ALDH1A1
Macrophage markers WP4146	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	CD163
Methylation Pathways WP704	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	HNMT
Endometrial cancer WP4155	3/63	0.20779366734203983	1.0	0	0	1.90857906288768	2.9987778901708264	BAX;BAK1;MAPK3
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	4/94	0.2078634121569063	1.0	0	0	1.705538737048565	2.6791866069280528	FZD2;FZD7;NKD1;EZH2
G1 to S cell cycle control WP45	3/64	0.2142944279585239	1.0	0	0	1.8787575150300602	2.8940463012915596	CDKN2D;PCNA;RPA3
Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	MAFG
Mammary gland development pathway - Involution (Stage 4 of 4) WP2815	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	BAX
Trans-sulfuration pathway WP2333	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	GCLM
B Cell Receptor Signaling Pathway WP23	4/97	0.22362462152626242	1.0	0	0	1.6527901163151044	2.475526607198604	GSK3A;IRF4;BTK;MAP2K6
Wnt Signaling in Kidney Disease WP4150	2/36	0.22632085176125513	1.0	0	0	2.22667557336896	3.308398103918243	FZD2;FZD7
Chemokine signaling pathway WP3929	6/164	0.22690287307260354	1.0	0	0	1.4663473288039492	2.1749350774586778	NCF1;CCL7;GNG4;WAS;ARRB1;MAPK3
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	3/66	0.2274211998774077	1.0	0	0	1.8218254691200584	2.698035115244598	FZD2;FZD7;CAMK1
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	3/66	0.2274211998774077	1.0	0	0	1.8218254691200584	2.698035115244598	RPS6KB1;MAPK3;MAP2K6
PPAR signaling pathway WP3942	3/67	0.234041265505709	1.0	0	0	1.7946340442078186	2.6062713442233294	FADS2;CD36;SLC27A2
TGF-beta Signaling Pathway WP366	5/132	0.2341151154693893	1.0	0	0	1.518187890933382	2.204321276097708	TGIF1;ITGA2;SKIL;MET;MAP2K6
Melatonin metabolism and effects WP3298	2/37	0.23558328242720192	1.0	0	0	2.1664951524670966	3.132082082352866	SULT1A1;SIRT1
Type II interferon signaling (IFNG) WP619	2/37	0.23558328242720192	1.0	0	0	2.1664951524670966	3.132082082352866	SPI1;IRF4
Circadian rhythm related genes WP3594	7/201	0.2374035027968392	1.0	0	0	1.3958264788283035	2.0071901603390128	DBP;PSPC1;ID3;NR1D1;SIRT1;ADA;EZH2
NAD metabolism, sirtuins and aging WP3630	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	SIRT1
Serotonin Transporter Activity WP1455	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	PPP2CB
Amyotrophic lateral sclerosis (ALS) WP2447	2/38	0.2448659994548925	1.0	0	0	2.1094821221390148	2.968134498606979	BAX;MAP2K6
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	3/69	0.24738022597343726	1.0	0	0	1.7426156661148384	2.4341356618782064	GSK3A;PRKACA;SIRT1
Bile Acids synthesis and enterohepatic circulation  WP4389	1/12	0.26160928125317606	1.0	0	0	3.34001336005344	4.4786345398527265	MAPK3
Ectoderm Differentiation WP2858	5/138	0.26213751662901774	1.0	0	0	1.4521797217623653	1.9443031574579013	BCAS3;BCOR;GAS2L1;ZBTB7B;SKIL
Bladder Cancer WP2828	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	RASSF1;UPK3A
Microglia Pathogen Phagocytosis Pathway WP3937	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	NCF1;SIGLEC7
Regulation of toll-like receptor signaling pathway WP1449	5/139	0.26688352910714297	1.0	0	0	1.4417323856345785	1.904446210876801	BTK;TLR8;CTNNAL1;MAP2K6;MAPK3
Chromosomal and microsatellite instability in colorectal cancer  WP4216	3/73	0.2743750837064334	1.0	0	0	1.6471298761907376	2.130165849626408	BAX;BAK1;MAPK3
EDA Signalling in Hair Follicle Development WP3930	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	LTB
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	KCNQ1
Kennedy pathway from Sphingolipids WP3933	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	CHKB
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	MAPK3
Osteopontin Signaling WP1434	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	MAPK3
Purine metabolism WP4224	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	ADA
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	IL11
Common Pathways Underlying Drug Addiction WP2636	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	PRKACA;MAPK3
DNA Replication WP466	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	PCNA;RPA3
IL-2 Signaling Pathway WP49	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	RPS6KB1;MAPK3
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	TNFSF12;MAPK3
Thermogenesis WP4321	4/108	0.2836481657215149	1.0	0	0	1.4844503822459734	1.8704381532354346	SMARCD3;RPS6KB1;PRKACA;CREB5
IL-6 signaling pathway WP364	2/43	0.29135825394517834	1.0	0	0	1.864193503285641	2.2989265149749634	RPS6KB1;MAPK3
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969	1/14	0.29801774237092626	1.0	0	0	2.86286859433152	3.4657951791914905	TULP3
Hedgehog Signaling Pathway WP4249	2/44	0.3006315833357493	1.0	0	0	1.8218254691200584	2.1895969020440007	ARRB1;PRKACA
Glycolysis and Gluconeogenesis WP534	2/45	0.30988425031274364	1.0	0	0	1.7813404586951682	2.0869408814372057	HK3;FBP1
Cholesterol Biosynthesis Pathway WP197	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	SC5D
Classical pathway of steroidogenesis, including diseases WP4523	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	H6PD
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	GPRC5A
Aryl Hydrocarbon Receptor Pathway WP2873	2/46	0.31911152054298275	1.0	0	0	1.7426156661148384	1.990441131153559	SERPINB2;BAX
Regulation of Microtubule Cytoskeleton WP2038	2/46	0.31911152054298275	1.0	0	0	1.7426156661148384	1.990441131153559	PRKACA;PHLDB2
Tryptophan metabolism WP465	2/46	0.31911152054298275	1.0	0	0	1.7426156661148384	1.990441131153559	ALDH2;ALDH1A1
DNA IR-damage and cellular response via ATR WP4016	3/80	0.3221955758514373	1.0	0	0	1.503006012024048	1.7022994079109226	PCNA;TDP1;TP53BP1
ID signaling pathway WP53	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	ID3
Interactome of polycomb repressive complex 2 (PRC2)  WP2916	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	EZH2
NAD+ metabolism WP3644	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	SIRT1
SREBF and miR33 in cholesterol and lipid homeostasis WP2011	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	SIRT1
Signaling Pathways in Glioblastoma WP2261	3/82	0.33589955964487944	1.0	0	0	1.4663473288039492	1.5997014907898262	MET;MAPK3;MAP2K6
Exercise-induced Circadian Regulation WP410	2/48	0.33747216444826783	1.0	0	0	1.67000668002672	1.814081910119734	PPP2CB;HLA-DMA
Alzheimers Disease WP2059	3/83	0.34274722112888345	1.0	0	0	1.4486804935171547	1.5511921213225777	LRP1;CAPN1;MAPK3
PI3K-Akt Signaling Pathway WP4172	10/340	0.3433427851229752	1.0	0	0	1.1788282447247436	1.260197992834022	PPP2CB;CSF1R;RPS6KB1;GNG4;HGF;ITGA2;PKN1;MET;CREB5;MAPK3
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	9/303	0.3449876778897502	1.0	0	0	1.1904998115041965	1.266985351515163	PPP2CB;CSF1R;RPS6KB1;GNG4;HGF;ITGA2;MET;CREB5;MAPK3
IL-3 Signaling Pathway WP286	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	PRKACA;MAPK3
Structural Pathway of Interleukin 1 (IL-1) WP2637	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	MAPK3;MAP2K6
IL-9 Signaling Pathway WP22	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	MAPK3
Leptin Insulin Overlap WP3935	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	DGKZ
Sulfation Biotransformation Reaction WP692	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	SULT1A1
Apoptosis WP254	3/84	0.34958922036658563	1.0	0	0	1.43143429716576	1.5044323931689507	IRF4;BAX;BAK1
MicroRNAs in cardiomyocyte hypertrophy WP1544	3/84	0.34958922036658563	1.0	0	0	1.43143429716576	1.5044323931689507	FZD2;MAPK3;MAP2K6
Hippo-Merlin Signaling Dysregulation WP4541	4/120	0.3513719994759129	1.0	0	0	1.3360053440213762	1.397341067695801	CSF1R;ITGA2;PRKACA;MET
Synaptic signaling pathways associated with autism spectrum disorder WP4539	2/50	0.35568043613445394	1.0	0	0	1.6032064128256514	1.6572707055198723	RPS6KB1;MAPK3
Epithelial to mesenchymal transition in colorectal cancer WP4239	5/159	0.36458577825486027	1.0	0	0	1.2603824000201662	1.2717175532580058	FZD2;FZD7;MAP2K6;EZH2;MAPK3
Estrogen metabolism WP697	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SULT1A1
Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	TLR8
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SIRT1
TCA Cycle (aka Krebs or citric acid cycle) WP78	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SUCLA2
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	MAPK3
Transcription co-factors SKI and SKIL protein partners WP4533	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SKIL
Insulin Signaling WP481	5/160	0.3695414659447132	1.0	0	0	1.25250501002004	1.2468591221422634	GSK3A;RPS6KB1;SH2B2;MAP2K6;MAPK3
Copper homeostasis WP3286	2/52	0.37370679355392844	1.0	0	0	1.5415446277169724	1.5173173477586306	PRNP;STEAP4
One carbon metabolism and related pathways WP3940	2/52	0.37370679355392844	1.0	0	0	1.5415446277169724	1.5173173477586306	CHKB;GCLM
VEGFA-VEGFR2 Signaling Pathway WP3888	7/236	0.37537369473925786	1.0	0	0	1.1888183145952924	1.1648436889574876	NCF1;RPS6KB1;TNFRSF10C;SLC8A1;HSPA1A;MAP2K6;MAPK3
Apoptosis Modulation by HSP70 WP384	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	HSPA1A
Cell Differentiation - Index expanded WP2023	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	EZH2
Overview of nanoparticle effects WP3287	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	BAX
Serotonin Receptor 4/6/7 and NR3C Signaling WP734	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	MAPK3
Small Ligand GPCRs WP247	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	S1PR1
TP53 Network WP1742	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	BAX
Interferon type I signaling pathways WP585	2/54	0.3915249643863088	1.0	0	0	1.4844503822459734	1.3919780295273776	RPS6KB1;MAP2K6
BMP Signaling Pathway in Eyelid Development WP3927	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	MAPK3
Imatinib and Chronic Myeloid Leukemia WP3640	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	CSF1R
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	MAPK3
Urea cycle and metabolism of amino groups WP497	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	ARG2
Cardiac Hypertrophic Response WP2795	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	MAPK3;MAP2K6
IL-1 signaling pathway WP195	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	MAPK3;MAP2K6
G Protein Signaling Pathways WP35	3/93	0.4105981346365888	1.0	0	0	1.2929083974400413	1.1508698913002264	RRAS;GNG4;PRKACA
Glycerophospholipid Biosynthetic Pathway WP2533	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	CHKB
Neovascularisation processes WP4331	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	MAPK3
Tamoxifen metabolism WP691	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	SULT1A1
Complement Activation WP545	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	C1R
PI3K/AKT/mTOR - VitD3 Signalling WP4141	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	HK3
Vitamin D in inflammatory diseases WP4482	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	MAP2K6
Blood Clotting Cascade WP272	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	SERPINB2
Estrogen signaling pathway WP712	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	PRKACA
Glutathione metabolism WP100	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	GCLM
Hippo-Yap signaling pathway WP4537	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	RASSF1
Pathways Regulating Hippo Signaling WP4540	3/98	0.44375323966298486	1.0	0	0	1.2269436832849372	0.9968753477201518	CSF1R;PRKACA;MET
TYROBP Causal Network WP3945	2/61	0.45193796213952664	1.0	0	0	1.314103617070206	1.043674707412875	CD4;ADAP2
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612	1/24	0.4548797623515939	1.0	0	0	1.67000668002672	1.3155012583860386	GCLM
GPCRs, Class A Rhodopsin-like WP455	7/257	0.46081917751346174	1.0	0	0	1.0916775184610465	0.8457766690097543	P2RY13;HRH2;FPR1;FFAR2;NMUR1;FPR2;CMKLR1
Integrin-mediated Cell Adhesion WP185	3/101	0.4632936620901169	1.0	0	0	1.1904998115041965	0.9159636102852832	ITGA2;CAPN1;MAP2K6
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	MAPK3
IL-7 Signaling Pathway WP205	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	MAPK3
MTHFR deficiency WP4288	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	HNMT
Lung fibrosis WP3624	2/63	0.4685698743106791	1.0	0	0	1.27238604192512	0.9645577423859204	HGF;SKIL
Toll-like Receptor Signaling Pathway WP75	3/103	0.47615319943251444	1.0	0	0	1.1673833103099402	0.8662166612664896	TLR8;MAP2K6;MAPK3
EPO Receptor Signaling WP581	1/26	0.48177439669322825	1.0	0	0	1.5415446277169724	1.1257581796782758	MAPK3
Glucuronidation WP698	1/26	0.48177439669322825	1.0	0	0	1.5415446277169724	1.1257581796782758	PGM3
Senescence and Autophagy in Cancer WP615	3/105	0.4888686316827337	1.0	0	0	1.145147437732608	0.8195379014770955	SERPINB2;PCNA;GSN
AGE/RAGE pathway WP2324	2/66	0.4929433227493972	1.0	0	0	1.2145503127467057	0.8591256155286086	NCF1;MAPK3
Canonical  and Non-canonical Notch signaling WP3845	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	RRAS
Intraflagellar transport proteins binding to dynein WP4532	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	WDR19
RAC1/PAK1/p38/MMP2 Pathway WP3303	2/68	0.5087948142513435	1.0	0	0	1.1788282447247436	0.7965465744715722	BAX;MAPK3
AMP-activated Protein Kinase (AMPK) Signaling WP1403	2/69	0.516598230750829	1.0	0	0	1.1617437774098922	0.7673199420538523	RPS6KB1;SLC2A4RG
Regulation of Actin Cytoskeleton WP51	4/150	0.5171892353197342	1.0	0	0	1.068804275217101	0.7047122999933597	GSN;RRAS;WAS;MAPK3
Lipid Metabolism Pathway WP3965	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	PRKACA
PDGFR-beta pathway WP3972	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	MAPK3
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	CD4
Statin Pathway WP430	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	LRP1
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	GSK3A
Dopaminergic Neurogenesis WP2855	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	ALDH1A1
Matrix Metalloproteinases WP129	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	MMP19
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	2/71	0.5319562504982418	1.0	0	0	1.1290186005814447	0.7126297992352149	TLR8;MAPK3
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	2/72	0.5395094657929208	1.0	0	0	1.11333778668448	0.6870351246335921	CR1;PCNA
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	RPS6KB1
IL17 signaling pathway WP2112	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	MAPK3
Toll-like Receptor Signaling WP3858	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	TLR8
Trans-sulfuration and one carbon metabolism WP2525	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	GCLM
Wnt Signaling WP428	3/115	0.5500298433977507	1.0	0	0	1.045569399668903	0.625023342167288	FZD2;FZD7;NKD1
Peptide GPCRs WP24	2/74	0.5543614743664991	1.0	0	0	1.0832475762335483	0.6390492598190445	FPR1;FPR2
Constitutive Androstane Receptor Pathway WP2875	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	SULT1A1
Development and heterogeneity of the ILC family WP3893	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	GFI1
Monoamine Transport WP727	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	PPP2CB
White fat cell differentiation WP4149	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	IRF4
ESC Pluripotency Pathways WP3931	3/116	0.5559064229339291	1.0	0	0	1.0365558703614124	0.6086192761094003	FZD2;FZD7;MAP2K6
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	4/158	0.5582266891996704	1.0	0	0	1.0146876030542096	0.5915528739029935	KCNQ1;MBD1;PRKACA;HSPD1
Alpha 6 Beta 4 signaling pathway WP244	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	MAPK3
Fluoropyrimidine Activity WP1601	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	CDA
Monoamine GPCRs WP58	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	HRH2
Oxidative Stress WP408	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	TXNRD1
Resistin as a regulator of inflammation WP4481	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	MAPK3
Signal transduction through IL1R WP4496	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	MAP2K6
Prolactin Signaling Pathway WP2037	2/76	0.568871397371907	1.0	0	0	1.0547410610695074	0.5949803665907504	RPS6KB1;MAPK3
BDNF-TrkB Signaling WP3676	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	RPS6KB1
Fatty Acid Beta Oxidation WP143	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	CHKB
p38 MAPK Signaling Pathway WP400	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	MAP2K6
Target Of Rapamycin (TOR) Signaling WP1471	1/36	0.5976367686206209	1.0	0	0	1.11333778668448	0.5731152526311586	RPS6KB1
Zinc homeostasis WP3529	1/36	0.5976367686206209	1.0	0	0	1.11333778668448	0.5731152526311586	SLC39A11
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	MTA2
miRNAs involvement in the immune response in sepsis WP4329	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	TLR8
Parkinsons Disease Pathway WP2371	1/38	0.617499951558055	1.0	0	0	1.0547410610695074	0.5084656565008984	LRRK2
Sleep regulation WP3591	1/38	0.617499951558055	1.0	0	0	1.0547410610695074	0.5084656565008984	ADA
PDGF Pathway WP2526	1/39	0.627061462527919	1.0	0	0	1.0276964184779815	0.4796369321136311	MAPK3
Pathways in clear cell renal cell carcinoma WP4018	2/85	0.629891951486803	1.0	0	0	0.9430625957797949	0.4358901142348933	HK3;CAMK1
Pyrimidine metabolism WP4022	2/85	0.629891951486803	1.0	0	0	0.9430625957797949	0.4358901142348933	CDA;POLR2D
Selenium Micronutrient Network WP15	2/86	0.6362406061926168	1.0	0	0	0.9320967516428205	0.42147408823246774	ALOX5;TXNRD1
ATM Signaling Pathway WP2516	1/40	0.6363844264214737	1.0	0	0	1.0020040080160322	0.4528581705268795	TP53BP1
Retinoblastoma Gene in Cancer WP2446	2/87	0.6425036413513994	1.0	0	0	0.921382995876811	0.4076039847564804	PCNA;RPA3
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	1/41	0.6454747830319615	1.0	0	0	0.9775648858692996	0.42794773473722786	CARD9
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	LMNA
Metabolic reprogramming in colon cancer WP4290	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	HK3
Allograft Rejection WP2328	2/89	0.6547741362150727	1.0	0	0	0.9006777600144108	0.38140544731754533	HLA-DMA;LRRK2
Cytoplasmic Ribosomal Proteins WP477	2/89	0.6547741362150727	1.0	0	0	0.9006777600144108	0.38140544731754533	RPS6KB1;RPS10
Androgen receptor signaling pathway WP138	2/90	0.6607823296802989	1.0	0	0	0.8906702293475841	0.3690321068194072	TGIF1;SIRT1
ErbB Signaling Pathway WP673	2/91	0.6667063671398114	1.0	0	0	0.8808826444096985	0.35711472102140146	RPS6KB1;MAPK3
GPCRs, Other WP117	2/91	0.6667063671398114	1.0	0	0	0.8808826444096985	0.35711472102140146	P2RY13;S1PR1
Integrated Cancer Pathway WP1971	1/44	0.6714074145685438	1.0	0	0	0.9109127345600292	0.3628886418772273	BAX
Corticotropin-releasing hormone signaling pathway WP2355	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	ARRB1;MAPK3
ATM Signaling Network in Development and Disease  WP3878	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	TP53BP1
Prostaglandin Synthesis and Regulation WP98	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	TBXAS1
Aryl Hydrocarbon Receptor WP2586	1/46	0.6876352184737552	1.0	0	0	0.8713078330574192	0.3263019842853477	CD36
Selenium Metabolism and Selenoproteins WP28	1/46	0.6876352184737552	1.0	0	0	0.8713078330574192	0.3263019842853477	TXNRD1
Energy Metabolism WP1541	1/47	0.6954466517190881	1.0	0	0	0.8527693685242825	0.3097266665191047	SIRT1
Rett syndrome causing genes WP4312	1/48	0.70306312169229	1.0	0	0	0.83500334001336	0.29417885952429185	HIVEP2
Hepatitis C and Hepatocellular Carcinoma WP3646	1/49	0.7104894851601173	1.0	0	0	0.8179624555232914	0.27958049222211656	MAPK3
Focal Adhesion WP306	4/198	0.7313639534988802	1.0	0	0	0.8097002084978038	0.2533098995828268	HGF;ITGA2;MET;MAPK3
Wnt Signaling Pathway WP363	1/52	0.7316747071553329	1.0	0	0	0.7707723138584862	0.2408041104693983	GSK3A
Nonalcoholic fatty liver disease WP4396	3/155	0.746603678064511	1.0	0	0	0.7757450384640249	0.22668882494900022	GSK3A;BAX;BAK1
Pathogenic Escherichia coli infection WP2272	1/55	0.7513125476348684	1.0	0	0	0.7287301876480233	0.20836840117723593	WAS
DNA Damage Response (only ATM dependent) WP710	2/110	0.7640186851414031	1.0	0	0	0.7287301876480233	0.19614722763586703	BAX;BAK1
Preimplantation Embryo WP3527	1/58	0.7695158178272834	1.0	0	0	0.6910372469076083	0.18104745348185977	IRF4
Ciliary landscape WP4352	4/216	0.7905450796004622	1.0	0	0	0.7422251911229867	0.1744471144259026	ERF;CDH23;GLA;LZTFL1
MECP2 and Associated Rett Syndrome WP3584	1/62	0.7917349773290154	1.0	0	0	0.6464541987200206	0.1509655231440861	EZH2
Endochondral Ossification WP474	1/64	0.802029442690977	1.0	0	0	0.62625250501002	0.13815754020836482	PRKACA
Cell Cycle WP179	2/120	0.8046053057444223	1.0	0	0	0.6680026720106881	0.14522606895436108	CDKN2D;PCNA
Oncostatin M Signaling Pathway WP2374	1/65	0.8069846249700656	1.0	0	0	0.616617851086789	0.13223410696801885	MAPK3
Pathways Affected in Adenoid Cystic Carcinoma WP3651	1/65	0.8069846249700656	1.0	0	0	0.616617851086789	0.13223410696801885	BCOR
Folate Metabolism WP176	1/66	0.8118160206220306	1.0	0	0	0.6072751563733528	0.12660565985377903	FOLR2
Histone Modifications WP2369	1/67	0.8165267159212919	1.0	0	0	0.5982113480692729	0.12125483627334348	EZH2
DNA Damage Response WP707	1/68	0.8211197204007441	1.0	0	0	0.5894141223623718	0.11616548243816698	BAX
mRNA Processing WP411	2/126	0.8258718290097254	1.0	0	0	0.63619302096256	0.12171370562826041	PRPF4;CLASRP
miRNA Regulation of DNA Damage Response WP1530	1/71	0.8342215710219	1.0	0	0	0.5645093002907223	0.10232083277541004	BAX
Adipogenesis WP236	2/130	0.8388708137781142	1.0	0	0	0.616617851086789	0.10833886899773712	LMNA;ID3
Endoderm Differentiation WP2853	2/141	0.8702080284548964	1.0	0	0	0.5685129123495217	0.07903636080669535	TRERF1;EZH2
Mesodermal Commitment Pathway WP2857	2/147	0.8848428940528873	1.0	0	0	0.5453083036821943	0.06671583743110317	PRKACA;TRERF1
EGF/EGFR Signaling Pathway WP437	2/162	0.9150046123317995	1.0	0	0	0.49481679408199114	0.043952682114619175	PCNA;RPS6KB1
Electron Transport Chain (OXPHOS system in mitochondria) WP111	1/103	0.9264047749877665	1.0	0	0	0.3891277701033134	0.02974649019550871	SLC25A6
Metapathway biotransformation Phase I and II WP702	2/183	0.9449777803150219	1.0	0	0	0.438034539023402	0.02479006741745062	SULT1A1;HNMT
